Edwards Lifesciences Corp. (EW) reported third quarter EPS of $0.71 after the close Wednesday, which beat the consensus estimate of $0.70. The company expects to report fourth quarter EPS of $0.82 to $0.86 and full year EPS of $3.02 to $3.06. The consensus estimates are for EPS of $0.83 and $3.03 respectively. Edwards Lifesciences gapped up slightly Thursday and rose steadily throughout the first 2 hours of trade. Shares traded in a range for the rest of the day and closed higher by $4.94 at $76.04 on the highest volume in 5 months. The stock has been on an upward trend since the beginning of September and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.